ArticleInternational journal of molecular sciences2026
Decellularized Testicular Extracellular Matrix Scaffolds Support Mature Spermatogenesis: Impact of Donor Age and Transplantation Microenvironment.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Immature testicular tissue transplantation is a promising strategy for restoring fertility in prepubertal boys undergoing gonadotoxic treatments, yet it faces challenges such as significant germ cell loss and poor graft survival due to the initial period without a blood supply. This study utilized an in vivo tissue-engineering platform involving decellularized testicular extracellular matrix to enhance graft stability and maturation. Immature testicular tissue from three-week-old transgenic mice was transplanted into age-matched recipient mice across four experimental groups: tissue co-transplanted with young decellularized matrix into a cleared testicular cavity, tissue with adult matrix in a cleared cavity, tissue transplanted alone in a cleared cavity, and tissue injected directly into an intact recipient testis. Graft growth was monitored longitudinally using bioluminescence imaging, and spermatogenesis was evaluated via histology and immunohistochemistry sixty-five days post-transplantation. The decellularization protocol successfully removed more than 98 percent of host deoxyribonucleic acid while preserving key matrix components. Grafts injected into intact testes showed the earliest bioluminescence peak but subsequently declined. Conversely, tissue co-transplanted with young decellularized matrix in a cleared cavity exhibited a delayed but significantly higher and more sustained peak compared to the group without a scaffold. The young matrix group appeared to provide more sustained support for spermatogenic progression, as reflected by a more stable increase and a prolonged spermatogenic peak over time. Evidence of advanced spermatogenic stages, including spermatids and sperm-like cells, was observed in all groups by day sixty-five. In conclusion, decellularized testicular matrix serves as a supportive bioactive scaffold that improves long-term graft stability, with outcomes significantly influenced by the age of the scaffold's donor and the transplantation microenvironment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.